Academic literature on the topic 'Philip Johnson Associates'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Philip Johnson Associates.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Philip Johnson Associates"
Chohan, S., A. Kavanaugh, V. Strand, R. C. Chou, A. M. Mendelsohn, S. Rozzo, and P. J. Mease. "AB0803 EFFICACY OF TILDRAKIZUMAB IN PsA: DAS28-CRP SCORES THROUGH WEEK 52." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1702–3. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3907.
Full textJayne, D., P. Gavin, E. Allman, C. Di Poto, X. Tian, S. Hess, M. Ramaswamy, et al. "OP0136 METABOLOMIC SERUM PROFILING IDENTIFIES METABOLITES LINKED TO KIDNEY DAMAGE WHICH ARE MODULATED BY ANIFROLUMAB IN A PHASE 2 TRIAL IN LUPUS NEPHRITIS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 90.1–90. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1569.
Full textPray, C., N. Narula, E. C. Wong, J. K. Marshall, S. Rangarajan, S. Islam, A. Bahonar, et al. "A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY." Journal of the Canadian Association of Gastroenterology 6, Supplement_1 (March 1, 2023): 20–22. http://dx.doi.org/10.1093/jcag/gwac036.176.
Full textRahman, P., C. T. Ritchlin, P. Helliwell, W. H. Boehncke, P. J. Mease, A. B. Gottlieb, S. Kafka, et al. "FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 776–77. http://dx.doi.org/10.1136/annrheumdis-2020-eular.387.
Full textRahman, P., P. J. Mease, A. Deodhar, A. Kavanaugh, S. D. Chakravarty, A. Kollmeier, Y. Liu, M. Shawi, and C. Han. "OP0025 FACTORS ASSOCIATED WITH FATIGUE AND ITS IMPROVEMENT – A PRINCIPAL COMPONENT ANALYSIS OF PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS FROM GUSELKUMAB PHASE 3 TRIALS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 18–19. http://dx.doi.org/10.1136/annrheumdis-2022-eular.895.
Full textCoates, L. C., C. T. Ritchlin, L. Gossec, P. Helliwell, P. Rahman, E. C. Hsia, A. Kollmeier, et al. "POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 781–82. http://dx.doi.org/10.1136/annrheumdis-2021-eular.167.
Full textCurtis, J., I. Mcinnes, D. D. Gladman, F. Yang, S. Peterson, P. Agarwal, A. Kollmeier, et al. "POS1028 PATIENT CHARACTERISTICS & CLINICAL FEATURES ASSOCIATE WITH HEALTH-RELATED QUALITY OF LIFE IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 784–85. http://dx.doi.org/10.1136/annrheumdis-2021-eular.432.
Full textCoates, L., J. Ramírez, D. Mcgonagle, S. Aydin, M. Zimmermann, F. Nantel, M. Shawi, E. Rampakakis, P. Nash, and P. J. Mease. "POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1137.1–1137. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2581.
Full textMcgonagle, D., I. Mcinnes, A. Deodhar, G. Schett, P. J. Mease, M. Shawi, S. Kafka, et al. "AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1701.2–1701. http://dx.doi.org/10.1136/annrheumdis-2020-eular.836.
Full textCurtis, J., I. McInnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier, et al. "AB0881 Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1563.2–1564. http://dx.doi.org/10.1136/annrheumdis-2022-eular.733.
Full textBooks on the topic "Philip Johnson Associates"
Architecture's odd couple: Frank Lloyd Wright and Philip Johnson. 2016.
Find full text